Hints and tips:
Related Special Reports
...Flumist is recommended in the US. This article has been corrected to remove an erroneous statement to the contrary....
...This month, Roche agreed to buy Carmot Therapeutics, a US start-up with potential GLP-1 drugs, for up to $3.1bn....
...Only the head of drugmaker AstraZeneca, who took home £16.9mn last year, and the head of cyber security company Darktrace, who earned £12mn in 2022, are paid more, according to the High Pay Centre think-tank...
...The discussion shows the significant restructuring multinational corporations could be forced to undertake as they adapt to growing friction between China and the US and its allies....
...“What you’ll see us doing . . . is to start to do bigger deals and deploy more equity,” he said....
...Shares in AstraZeneca dipped 1.1 per cent in morning trading....
...AstraZeneca also announced on Monday that the drug had been approved to be used alongside chemotherapy in the US to treat the same form of lung cancer at an advanced stage, where it extended progression-free...
...He was the technical lead in chemical development for Truqap, which was approved by the US’s Food and Drug Administration in November to treat some forms of breast cancer....
...by other sectors because of its geopolitical rift with the US....
...London-listed shares in the drugmaker rose by 1.4 per cent in morning trading on Tuesday, while Icosavax surged 45 per cent before the US open....
...AstraZeneca has signed a deal worth up to $247mn with Absci Corporation of the US to design an antibody to fight cancer, the latest tie-up in fast-expanding efforts to use artificial intelligence for drug...
...Shares in Daiichi soared 14 per cent on Friday after the deal was announced, while Merck, known as MSD outside the US, gained 1.6 per cent....
...AstraZeneca has settled disputes on drugs Nexium and Prilosec for a combined total of $425mn, “effectively” resolving product liability claims in some US states....
...Wegovy’s official list price in the UK is about £175.80 per pack of 2.4mg doses — about a sixth of the US list price, though health systems and insurers, including the NHS, negotiate confidential discounts...
...AstraZeneca has settled disputes on stomach drugs Nexium and Prilosec for a combined total of $425mn, “effectively” resolving product liability claims in some US states....
...AstraZeneca: Shares rose 3.4 per cent after its drug Tagrisso was approved in the US to be used alongside chemotherapy for lung cancer patients....
...AstraZeneca has become the latest large pharmaceutical company to sue the US over a law that allows the government to negotiate some drug prices for the first time....
...crunchy acronym was coined by Goldman Sachs for pharma companies GSK and Roche, Dutch chip company ASML, Switzerland’s Nestlé and Novartis, Danish drugmaker Novo Nordisk, France’s L’Oréal and LVMH, the UK’s AstraZeneca...
...That will hit companies like AstraZeneca, maker of oral cancer drugs such as Tagrisso. It should still be manageable. Analysts expect US oncology to account for 17 per cent of overall revenues in 2025....
...London’s FTSE 100 — which rose 0.2 per cent — was pushed up by strong gains for AstraZeneca, whose drug Tagrisso was approved by regulators as part of a treatment plan for lung cancer patients in the US....
...London’s FTSE 100 slipped 0.1 per cent, even as shares in UK-based pharmaceuticals group AstraZeneca rose 3.7 per cent after its cancer drug Tagrisso was approved as part of a treatment plan in the US....
...London’s FTSE 100 rose 0.2 per cent — led higher by strong gains for index heavyweight AstraZeneca, whose drug Tagrisso was approved by US regulators to be used alongside chemotherapy for lung cancer patients...
...Soriot echoed other pharmaceutical industry leaders in criticising the US drug pricing reforms in the Inflation Reduction Act....
...GBA’s nearly 200 members include large companies from a range of sectors, including Nestlé USA, AstraZeneca, Diageo, Mercedes-Benz, Panasonic, Sony Corporation of America and chipmaker TSMC....
International Edition